Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 4
187
Views
5
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Inhibitory effect of ketoconazole, quinidine and 1-aminobenzotriazole on pharmacokinetics of l-tetrahydropalmatine and its metabolite in rats

, , , , , & show all
Pages 447-454 | Received 12 Nov 2020, Accepted 19 Dec 2020, Published online: 07 Jan 2021

References

  • Abdallah, I.A., et al., 2017. Development and validation of a high performance liquid chromatography quantification method of levo-tetrahydropalmatine and its metabolites in plasma and brain tissues: application to a pharmacokinetic study. Biomedical chromatography, 31 (4), e3850.
  • Center for Drug Evaluation and Research., 2001. Guidance for industry: bioanalytical method validation. Beltsville, MD: CDER.
  • Dogra, A., et al., 2018. Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: a possible risk for long-term use. Phytotherapy research, 32 (10), 1967–1974.
  • Fujioka, Y., Kunze, K.L., and Isoherranen, N., 2012. Risk assessment of mechanism-based inactivation in drug-drug interactions. Drug metabolism and disposition: the biological fate of chemicals, 40 (9), 1653–1657.
  • Giri, P., et al., 2018. Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on the in vivo cytochrome P450 2D (CYP2D) enzyme in rats: effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA. Xenobiotica; the fate of foreign compounds in biological systems, 48 (1), 1–10.
  • Greenblatt, D.J. and Harmatz, J.S., 2015. Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies. British journal of clinical pharmacology, 80 (3), 342–350.
  • Guo, X., et al., 1997. Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf striatum. Zhongguo yao li xue bao, 18 (3), 225–230.
  • Guo, Y., et al., 2011. CYP2D plays a major role in berberine metabolism in liver of mice and humans. Xenobiotica; the fate of foreign compounds in biological systems, 41 (11), 996–1005.
  • Hassan, H.E., et al., 2017. Pharmacokinetics and safety assessment of l-tetrahydropalmatine in cocaine users: a randomized, double-blind, placebo-controlled study. Journal of clinical pharmacology, 57 (2), 151–160.
  • Hu, Y., et al., 2006. Therapeutic effects of rotundine combined with methadone in treatment of heroin dependence. Chinese journal of drug abuse prevention and treatment, 12 (5), 270–271.
  • Hu, Y.H., et al., 2017. Levo-Corydalmine alleviates neuropathic cancer pain induced by tumor compression via the CCL2/CCR2 pathway. Molecules, 22 (6), 937.
  • Isoherranen, N., et al., 2009. Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database. Chemical research in toxicology, 22 (2), 294–298.
  • Kotsuma, M., et al., 2008. Effects of ketoconazole and quinidine on pharmacokinetics of pactimibe and its plasma metabolite, R-125528, in humans. Drug metabolism and disposition: the biological fate of chemicals, 36 (8), 1505–1511.
  • Li, C.Z., et al., 2010. In vitro O-demethylation of rotundine by recombinant human CYP isoenzymes. Acta pharmaceutica sinica, 45 (3), 307–313.
  • Li, Z., et al., 2019. Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4′-hydroxylation: a comparison with ABT for drug ADME optimization and mechanism study. European journal of pharmaceutical sciences, 130, 156–165.
  • Liu, Y.L., et al., 2009. Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats. European journal of pharmacology, 602 (2–3), 321–327.
  • Mou, Y.Y. and Yu, B.Y., 2006. Identification of rotundine metabolites in rat bile by HPLC/MS/MS. Chinese journal of natural medicines, 4, 448–451.
  • Mou, Y.Y. and Yu, B.Y., 2009. Identification of rotundine metabolites in rat bile using liquid chromatography coupled with electrospray ionization mass spectrometry (II). Chinese journal of natural medicines, 7 (4), 312–314.
  • Padmanabhan, S., et al., 2019. Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat. Xenobiotica; the fate of foreign compounds in biological systems, 49 (6), 646–654.
  • State Pharmacopeia Committee., 2010. Pharmacopoeia of the People’s Republic of China part I. Bejing, China: Chinn Medical Science Press, 130–131.
  • Smith, R.J. and Aston-Jones, G., 2008. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain structure & function, 213 (1–2), 43–61.
  • Shah, V.P., et al., 2000. Bioanalytical method validation-a revisit with a decade of progress. Pharmaceutical research, 17 (12), 1551–1557.
  • Shen, L., et al., 2019. Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro. Drug testing and analysis, 11 (4), 595–600.
  • Sun, S.Y., et al., 2012. The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Xenobiotica; the fate of foreign compounds in biological systems, 42 (12), 1197–1205.
  • Wang, J.B. and Mantsch, J.R., 2012. l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction. Future medicinal chemistry, 4 (2), 177–186.
  • Wang, Q., et al., 2019. Drug-drug interactions of amiodarone and quinidine on the pharmacokinetics of Eliglustat in rats. Drug design, development and therapy, 13, 4207–4213.
  • Wang, W., et al., 2017. Simultaneous determination of L-tetrahydropalmatine and its active metabolites in rat plasma by a sensitive ultra-high-performance liquid chromatography with tandem mass spectrometry method and its application in a pharmacokinetic study. Biomedical chromatography, 31 (6), e3903.
  • Watanabe, A., et al., 2016. In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice. Biopharmaceutics & drug disposition, 37 (6), 373–378.
  • Xiao, W.B., et al., 2014. Simultaneous quantification of l-tetrahydropalmatine and its urine metabolites by ultra high performance liquid chromatography with tandem mass spectrometry. Journal of separation science, 37 (6), 696–670.
  • Xiao, W.B., et al., 2016. Characterization of human metabolism and disposition of levo-tetrahydropalmatine: qualitative and quantitative determination of oxidative and conjugated metabolites. Journal of pharmaceutical and biomedical analysis, 128, 371–381.
  • Xu, S.X., et al., 1989. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Acta pharmacologica sinica, 10 (2), 104–110.
  • Xu, W., et al., 2013. l-Isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors. Drug and alcohol dependence, 133 (2), 693–703.
  • Yang, K., Hye Koh, K., and Jeong, H., 2010. Induction of CYP2B6 and CYP3A4 expression by 1-aminobenzotriazole (ABT) in human hepatocytes. Drug metabolism letters, 4 (3), 129–133.
  • Yang, Z., et al., 2008. Medication of L-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta pharmacologica sinica, 29 (7), 781–788.
  • Younis, I.R., et al., 2019. Drug-drug interaction studies of methadone and antiviral drugs: lessons learned. Journal of clinical pharmacology, 59 (8), 1035–1043.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.